Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Jan;19(1):6.
doi: 10.1038/s41569-021-00651-z.

No benefit of sacubitril-valsartan after acute MI

Gregory B Lim  1
Affiliations
Comment

No benefit of sacubitril-valsartan after acute MI

Gregory B Lim. Nat Rev Cardiol. 2022 Jan.
No abstract available

PubMed Disclaimer

Comment on

  • Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction.
    Pfeffer MA, Claggett B, Lewis EF, Granger CB, Køber L, Maggioni AP, Mann DL, McMurray JJV, Rouleau JL, Solomon SD, Steg PG, Berwanger O, Cikes M, De Pasquale CG, East C, Fernandez A, Jering K, Landmesser U, Mehran R, Merkely B, Vaghaiwalla Mody F, Petrie MC, Petrov I, Schou M, Senni M, Sim D, van der Meer P, Lefkowitz M, Zhou Y, Gong J, Braunwald E; PARADISE-MI Investigators and Committees. Pfeffer MA, et al. N Engl J Med. 2021 Nov 11;385(20):1845-1855. doi: 10.1056/NEJMoa2104508. N Engl J Med. 2021. PMID: 34758252 Clinical Trial.

Similar articles

See all similar articles

References

Original article
    1. Pfeffer, M. A. et al. Angiotensin receptor–neprilysin inhibition in acute myocardial infarction. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2104508 (2021) - DOI - PubMed - PMC

LinkOut - more resources